Parabilis Medicines, Inc. (PBLS)
:PBLS
PBLS Stock Chart & Stats
$27.26
-$3.05(-10.06%)
―
--
Day’s Range― - ―
52-Week Range$26.61 - $34.47
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
$3.18B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding116,564,570
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PBLS FAQ
What was Parabilis Medicines, Inc.’s price range in the past 12 months?
Parabilis Medicines, Inc. lowest stock price was $26.61 and its highest was $34.47 in the past 12 months.
What is Parabilis Medicines, Inc.’s market cap?
Parabilis Medicines, Inc.’s market cap is $3.18B.
When is Parabilis Medicines, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Parabilis Medicines, Inc.’s earnings last quarter?
Currently, no data Available
Is Parabilis Medicines, Inc. overvalued?
According to Wall Street analysts Parabilis Medicines, Inc.’s price is currently Undervalued.
Does Parabilis Medicines, Inc. pay dividends?
Parabilis Medicines, Inc. does not currently pay dividends.
What is Parabilis Medicines, Inc.’s EPS estimate?
Parabilis Medicines, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Parabilis Medicines, Inc. have?
Parabilis Medicines, Inc. has 116,564,570 shares outstanding.
What happened to Parabilis Medicines, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Parabilis Medicines, Inc.?
Currently, no hedge funds are holding shares in PBLS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Parabilis Medicines, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
Parabilis Medicines, Inc.
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Ownership Overview
Options Prices
Currently, No data available
---